دورية أكاديمية
Upfront or intermediate treatment of advanced ovarian cancer patients with cytoreduction plus HIPEC: Results of a retrospective study.
| العنوان: | Upfront or intermediate treatment of advanced ovarian cancer patients with cytoreduction plus HIPEC: Results of a retrospective study. |
|---|---|
| المؤلفون: | Spiliotis, John, Iavazzo, Christos, Fotiou, Alexandros, Kopanakis, Nikolaos, Terra, Alexios, Efstathiou, Elias, Margari, Charalambia, Tsiatas, Marinos |
| المصدر: | J Surg Oncol ; ISSN:1096-9098 ; Volume:123 ; Issue:2 |
| بيانات النشر: | Wiley |
| سنة النشر: | 2021 |
| المجموعة: | PubMed Central (PMC) |
| مصطلحات موضوعية: | HIPEC, intermediate, ovarian cancer, survival, upfront |
| الوصف: | Newly diagnosed advanced-stage ovarian cancer patients are treated with neoadjuvant chemotherapy, primary or intermediate cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy (HIPEC). The aim of this study is to evaluate the optimal timing of cytoreduction plus HIPEC for advanced ovarian cancer patients. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | https://doi.org/10.1002/jso.26280Test; https://pubmed.ncbi.nlm.nih.gov/33125733Test |
| DOI: | 10.1002/jso.26280 |
| الإتاحة: | https://doi.org/10.1002/jso.26280Test https://pubmed.ncbi.nlm.nih.gov/33125733Test |
| حقوق: | © 2020 Wiley Periodicals LLC. |
| رقم الانضمام: | edsbas.CF5F1471 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1002/jso.26280 |
|---|